VIRTUAL | Join D2R for a learning opportunity to gain foundational knowledge and practical tools to embed Equity, Diversity, and Inclusion (EDI) into your genomic-based RNA therapeutics research. Through engaging discussions and activities, participants will explore key EDI definitions, examine both opportunities and challenges in the field, and learn best practices for inclusive research design.


Maximizing the value of your company’s IP assets
According to Stats Canada, “Canadian businesses are among the most innovative in the world. Those that are able to leverage and use their Intellectual Property (IP) strategically are more likely to be innovative, expand domestically and internationally, and experience high growth.” IP-intensive firms are more innovative, export more, enjoy higher growth and create better jobs.

The 7th Annual Quebec Extracellular Vesicles Workshop (QEVW2025) is just around the corner! Join McGill Center for Applied Nanomedicine on Tuesday, November 25, 2025, from 9:00 AM to 4:00 PM EST at the Research Institute of the McGill University Health Center (RI-MUHC) - Sylvia & Richard Cruess Auditorium and Block E Atrium in Montreal.
This year’s program features two keynote speakers:

Neurogenesis Speaker Series - Meet HBHL-supported Faculty!
Wednesday, November 26, 2025
4:30–5:30 p.m. (with post-event reception)
The Neurogenesis Speaker Series is an opportunity to get to know HBHL-supported faculty recruits firsthand, learn about their research, ask questions and network with your peers during the post-event reception.
Each event in this series will feature two HBHL faculty recruits whose research areas provide an interesting contrast or intersection for discussion.

Every year, billions of dollars are invested by funding agencies in basic and translational research, yet the path from academic discovery to private investment necessary for the creation of new companies is rarely straightforward. In this seminar, you'll get an inside look at how investors work, what makes a research idea stand out to venture capitalists, and how they evaluate translational value of scientific opportunities. By the end of the session, you’ll have a clearer grasp of the framework needed to transition an idea or mechanism discovered in the lab to an investment phase.

Join the McGill Centre for Translational Research for CTR Horizons 2025